Valuation: Traphaco

Market Cap 3,076B 118M 104M 98.49M 89.33M 168M 11.37B 169M 1.18B 455M 5.8B 445M 435M 18.64B P/E 2024
15.7x
P/E 2025 14.3x
Enterprise Value 2,506B 96.5M 84.87M 80.26M 72.8M 137M 9.26B 138M 961M 371M 4.73B 362M 354M 15.19B EV / Sales 2024
1.16x
EV / Sales 2025 0.96x
Free-Float
77.72%
Yield 2024
5.1%
Yield 2025 -
Sep. 13 Traphaco Joint Stock Company Announces Change in Enterprise Registration Certificate CI
Sep. 02 Traphaco Joint Stock Company Announces Appointment of Nguyen Phu Khanh as Deputy General Director for Finance and Planning, Effective August 25, 2026 CI
Aug. 26 Traphaco Joint Stock Company Appoints Nguyen Phu Khanh as Chief Finance Officer, Effective August 25, 2026 CI
Aug. 26 Traphaco Joint Stock Company Appoints Nguy?n Phú Khánh as Chief Finance & Planning Officer, Effective August 25, 2026 CI
Aug. 20 Traphaco Joint Stock Company Approves Termination of Operations of Binh Thuan Branch CI
Jul. 31 Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
Jul. 20 Traphaco Joint Stock Company Announces to Pay Second Cash Dividend for the Year 2025, Payable on August 7, 2026 CI
Jul. 08 Traphaco Joint Stock Company Approves the Dismissal of Pham Hoang Anh from the Position Chief Finance & Planning Officer, Effective from July 06, 2026 CI
Jul. 08 Traphaco Joint Stock Company Approves the Dismissal of Pham Hoang Anh from the Position Chief Finance & Planning Officer, Effective from July 06, 2026 CI
Apr. 28 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Feb. 23 Traphaco Joint Stock Company Receives Large Enterprise Tax Department Decision on Tax Inspection and Administrative Penalties for Fiscal Years 2023 and 2024 CI
Jan. 29 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
Dec. 26 Traphaco Joint Stock Company Announces First Cash Dividend Payment in 2025, Payable on January 28, 2026 CI
1 day+0.54%
1 week+1.50%
Current month+0.27%
1 month+0.27%
3 months-8.85%
6 months+9.12%
Current year-1.07%
1 week 36,500
Extreme 36500
38,950
1 month 35,550
Extreme 35550
38,950
Current year 32,500
Extreme 32500
41,400
1 year 31,500
Extreme 31500
41,400
3 years 31,500
Extreme 31500
45,000
5 years 31,500
Extreme 31500
51,850
10 years 21,550
Extreme 21550
71,000
Manager TitleAgeSince
Chief Executive Officer 61 2012-09-16
Corporate Secretary - 2018-03-29
Comptroller/Controller/Auditor 44 1993-12-31
Director TitleAgeSince
Chairman 70 2010-10-17
Director/Board Member 61 1993-12-31
Director/Board Member 48 2016-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
4/15/25 Buy 33,264 0.0802%
10/5/23 Sell

Executive/Senior Manager

7,200 0.0174%
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%+1.50%+11.08%-11.98% 118M
+0.11%+1.71%+63.52%+117.61% 1,056B
+0.27%+0.92%+51.33%+73.35% 655B
+0.73%+0.68%+20.70%+74.90% 471B
-1.72%-3.65%+36.98%+40.07% 342B
-0.45%+4.12%+22.42%+29.18% 277B
-0.08%-0.88%+13.28%+13.13% 257B
+0.85%+6.35%+53.17%+54.39% 226B
+0.85%+1.10%+35.78%+101.82% 189B
-0.31%-2.59%-28.28%-60.85% 170B
Average -0.19%+0.90%+28.00%+43.16% 364.3B
Weighted average by Cap. -0.22%+1.04%+40.27%+69.69%

Financials

2024 2025
Net sales 2,347B 90.38M 79.49M 75.17M 68.18M 128M 8.68B 129M 900M 348M 4.43B 339M 332M 14.23B 2,657B 102M 89.99M 85.09M 77.18M 145M 9.82B 146M 1.02B 393M 5.01B 384M 376M 16.1B
Net income 239B 9.2M 8.09M 7.65M 6.94M 13.04M 883M 13.11M 91.64M 35.39M 451M 34.55M 33.8M 1.45B 250B 9.61M 8.45M 7.99M 7.25M 13.62M 923M 13.7M 95.72M 36.97M 471M 36.09M 35.31M 1.51B
Net Debt -540B -20.81M -18.3M -17.31M -15.7M -29.48M -2B -29.65M -207M -80.03M -1.02B -78.13M -76.44M -3.28B -569B -21.92M -19.28M -18.23M -16.54M -31.06M -2.1B -31.24M -218M -84.31M -1.07B -82.31M -80.53M -3.45B
Logo Traphaco
Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Employees
1,546
Date Price Change Volume
26-09-28 ₫37,100.00 +0.54% 7,016
26-09-25 ₫36,900.00 +0.27% 3,313
26-09-24 ₫36,800.00 -5.52% 622
26-09-23 ₫38,950.00 +5.27% 13,259
26-09-22 ₫37,000.00 +1.23% 7,035

Net sales - Rate of surprise